DailyStocks Stock Article Search

https://seekingalpha.com/news/4068613-healthcare-dealmakers-see-increased-ma-valuations-in-2024-kpmg?source=feed_sector_healthcare Feb 19, 2024 - Corporate and private equity dealmakers are anticipating an uptick in healthcare and life sciences M&A activity this year, with higher valuations, according to KPMG survey. 0

https://www.zacks.com/stock/news/2227980/wall-street-analysts-see-a-75-05-upside-in-hutchmed-hcm-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2227980 Feb 19, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 75.1% in HUTCHMED (HCM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2227977/wall-street-analysts-see-a-26-61-upside-in-esquire-financial-holdings-inc-esq-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2227977 Feb 19, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in Esquire Financial Holdings, Inc. (ESQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2227905/wall-street-analysts-see-builders-firstsource-bldr-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2227905 Feb 19, 2024 - The average brokerage recommendation (ABR) for Builders FirstSource (BLDR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock? 0

https://www.zacks.com/stock/news/2227817/what-s-in-the-offing-for-flowserve-fls-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227817 Feb 19, 2024 - Flowserve's (FLS) fourth-quarter 2023 results are likely to benefit from strength in its Pump Division segment, driven by higher aftermarket and original equipment customer sales. 0

https://www.fool.com/investing/2024/02/19/magnificent-7-stock-shake-up-3-business-stats-you/?source=iedfolrf0000001 Feb 19, 2024 - By one metric, Nvidia just surpassed Alphabet and Amazon in size. 0

https://www.zacks.com/stock/news/2227424/what-s-in-the-offing-for-allegion-alle-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227424 Feb 16, 2024 - Strength in the Allegion Americas segment and accretive acquisition are likely to aid Allegion's (ALLE) fourth-quarter 2023 results. 0

https://seekingalpha.com/article/4670634-teva-pharmaceutical-i-need-to-see-growth-before-starting-a-position?source=feed_tag_israel Feb 15, 2024 - Teva Pharmaceutical's weak financial performance, declining revenues, and industry uncertainties make it a risky investment. Read why I rate TEVA stock a hold. 0

https://www.zacks.com/stock/news/2226288/pre-markets-do-not-see-the-sky-falling?cid=CS-ZC-FT-ahead_of_wall_street-2226288 Feb 14, 2024 - The Inflation Rate came in a mere 20 bps higher than anticipated. That's not exactly "Chicken Little." 0

https://www.rttnews.com/story.aspx?Id=3424551 Feb 14, 2024 - The major U.S. index futures are currently pointing to a higher open on Wednesday, with stocks likely to regain ground following the sell-off seen in the previous session. 0